EUVIMEDEUVIMED entdecken
Crossref

Exploring the phenotypic expression of HLA-B27 in psoriatic arthritis

Cristina Macia-Villa, Jose Ignacio Fernandez-Velasco, Mauro Ferre-Sanfrancisco, Daniel Albert Mendoza-Bravo, Ana Maria Ruiz-Bejerano, Celia Ferrez-Hernandez, Jose Luis Morell-Hita

Clinical Rheumatology · 2026-06 · 45 (6) · 3399-3404

DOI: 10.1007/s10067-026-08144-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 25.04.2026. Verfasst von Cristina Macia-Villa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, University Hospital Ramón y Cajal, Madrid, Spain. ccmacia@gmail.com. Hauptthemen laut MEDLINE: HLA-B27 Antigen, Arthritis, Psoriatic. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION/OBJECTIVES: Psoriatic arthritis (PsA) is a heterogeneous inflammatory disease within the spectrum of spondyloarthritis (SpA) that shares genetic and clinical features with other subtypes. HLA-B27 is a well-established genetic risk allele for axial SpA, while its role in PsA is less clear. This study aimed to investigate the association between HLA-B27 and the clinical, laboratory, and therapeutic features of a real-world PsA cohort. METHOD: We performed a retrospective analysis of 333 patients with PsA who fulfilled the CASPAR criteria and had documented HLA-B27 status. Demographic, clinical, laboratory, and treatment-related data were extracted from medical records. Patients were compared based on HLA-B27 positivity using appropriate statistical analyses. Statistical significance was set at p < 0.05. RESULTS: HLA-B27 was positive in 11.7% of patients. Compared with HLA-B27-negative individuals, HLA-B27-positive patients showed significantly earlier PsA onset (42.8 vs. 49.1 years, p = 0.003), more frequent axial involvement (46.2% vs. 24.5%, p = 0.004), and higher prevalence of enthesitis (33.3% vs. 18.4%, p = 0.028). CRP levels were also higher in HLA-B27-positive patients (median 5.5 vs. 3.2 mg/L, p = 0.015). No significant differences were observed in sex, dactylitis, uveitis, treatment response, comorbidities, or frequency of difficult-to-treat and treatment-refractory disease between the two groups. Interestingly, HLA-B27 negativity was associated with higher FIB-4 scores (p = 0.034), a marker of hepatic fibrosis. CONCLUSIONS: HLA-B27 is associated with a distinct clinical phenotype in PsA, including earlier onset, axial disease, enthesitis, and elevated systemic inflammation. These findings highlight the relevance of HLA-B27 in PsA stratification and support its role in identifying disease profiles. Key Points • HLA-B27 positivity was associated with an earlier PsA onset, axial involvement, and enthesitis. • Elevated CRP levels in HLA-B27-positive patients suggest increased systemic inflammation in this profile. • HLA-B27 status did not significantly affect the treatment response, comorbidities, or frequency of difficult-to-manage/refractory PsA. • HLA-B27 may help in the clinical stratification of PsA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA-B27 AntigenArthritis, PsoriaticHumansMaleFemaleMiddle AgedAdultRetrospective StudiesPhenotypeGenetic Predisposition to DiseaseC-Reactive Protein

Stichwörter der Autor:innen

HLAaxialcomorbiditiesenthesisinflammationpsoriatic arthritisspondyloarthritis

Substanzen

HLA-B27 AntigenC-Reactive Protein

Autor:innen und Institutionen

  • Rheumatology Department, University Hospital Ramón y Cajal, Madrid, Spain. ccmacia@gmail.com.
  • Inmunology Department, University Hospital Ramón y Cajal, Madrid, Spain.
  • Rheumatology Department, University Hospital Ramón y Cajal, Madrid, Spain.

Zitieren

APA

Macia-Villa, C., Fernandez-Velasco, J. I., Ferre-Sanfrancisco, M., Mendoza-Bravo, D. A., Ruiz-Bejerano, A. M., Ferrez-Hernandez, C., & Morell-Hita, J. L. (2026). Exploring the phenotypic expression of HLA-B27 in psoriatic arthritis. Clinical Rheumatology, 45(6), 3399-3404. https://doi.org/10.1007/s10067-026-08144-5

Vancouver

Macia-Villa C, Fernandez-Velasco JI, Ferre-Sanfrancisco M, Mendoza-Bravo DA, Ruiz-Bejerano AM, Ferrez-Hernandez C, et al. Exploring the phenotypic expression of HLA-B27 in psoriatic arthritis. Clinical Rheumatology. 2026;45(6):3399-3404. doi:10.1007/s10067-026-08144-5

BibTeX
@article{MaciaVilla2026,
  author = {Macia-Villa, Cristina and Fernandez-Velasco, Jose Ignacio and Ferre-Sanfrancisco, Mauro and Mendoza-Bravo, Daniel Albert and Ruiz-Bejerano, Ana Maria and Ferrez-Hernandez, Celia and Morell-Hita, Jose Luis},
  title = {Exploring the phenotypic expression of HLA-B27 in psoriatic arthritis},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {6},
  pages = {3399--3404},
  doi = {10.1007/s10067-026-08144-5}
}
Kostenlos starten →